Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are the leading causes of systemic sclerosis (SSc)-associated death, and there's increasing interest in patients with the ...
The British Society for Rheumatology has produced its first guidelines for the diagnosis and management of systemic ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Detection and treatment of interstitial lung disease in systemic sclerosis calls for early and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Concurrent pulmonary arterial hypertension and ...
SAN FRANCISCO--(BUSINESS WIRE)--The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Sanofi will contribute the first ...
SSc is a rare connective tissue disorder, with both autoimmune and vascular features. The main hallmark is tissue and vascular fibrosis that can result in clinical heterogeneity of manifestations ...
Hosted on MSN
Living better with scleroderma lung disease
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a serious complication affecting up to half of people with scleroderma, and it’s a leading cause of death. New guidelines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results